Cardiovascular risk and the use of biologic agents in rheumatoid arthritis.
about
Concomitant Use of Statins in Tocilizumab-Treated Patients with Rheumatoid Arthritis: A Post Hoc Analysis.Sudden cardiac death in patients with rheumatoid arthritisThe Impact of Biologics and Tofacitinib on Cardiovascular Risk Factors and Outcomes in Patients with Rheumatic Disease: A Systematic Literature Review.Lipids and Atherogenic Indices Fluctuation in Rheumatoid Arthritis Patients on Long-Term Tocilizumab Treatment
P2860
Cardiovascular risk and the use of biologic agents in rheumatoid arthritis.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Cardiovascular risk and the use of biologic agents in rheumatoid arthritis.
@en
type
label
Cardiovascular risk and the use of biologic agents in rheumatoid arthritis.
@en
prefLabel
Cardiovascular risk and the use of biologic agents in rheumatoid arthritis.
@en
P2093
P2860
P1476
Cardiovascular risk and the use of biologic agents in rheumatoid arthritis.
@en
P2093
Amy C Cannella
Debbie T Lim
Kaleb D Michaud
Ted R Mikuls
P2860
P2888
P356
10.1007/S11926-014-0459-Y
P577
2014-11-01T00:00:00Z
P6179
1012551410